OTC Markets Group Extends Invitation to PetVivo Holdings Inc., Joining OTCQX Ranks
PetVivo Holdings Inc., an emerging biomedical device company based in Edina, Minnesota, has made a significant stride in its growth trajectory by qualifying to trade on the OTCQX Best Market. This milestone reflects the company's compliance with high financial standards, best practice corporate governance, and adherence to securities laws.
PetVivo Holdings Inc. specializes in manufacturing, commercializing, and licensing innovative medical devices and therapeutics for horses and companion animals. The company's lead product, Spryng® with OsteoCushion® Technology, is an intra-articular injection used to manage lameness and joint conditions in dogs and horses, commercially available since mid-2022.
PetVivo has developed a robust portfolio, including 18 products in the pipeline, 12 patents, and 6 proprietary trade secrets. The company operates an ISO 7 certified clean room manufacturing facility in Minneapolis and plans to expand manufacturing capacity with a second facility to reduce supply risks.
To learn more about PetVivo Holdings Inc., visit their official website at https://petvivo.com/, https://www.petvivoanimalhealth.com/, or https://www.sprynghealth.com/. You can also contact them at [email protected].
The OTCQX Market is designed for established, investor-focused U.S. and international companies. OTC Markets Group Inc., the operator of these regulated markets, oversees trading for over 12,000 U.S. and international securities. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.
Trading on OTCQX under the symbol "PETV" enhances the company’s visibility among U.S. investors. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for PetVivo Holdings Inc. on www.otcmarkets.com.
OTC Markets Group Inc.'s OTC Link Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. The company's data-driven disclosure standards form the foundation of its public markets: OTCQX® Best Market, OTCQB® Venture Market, OTCID™ Basic Market, and Pink Limited™ Market.
For media inquiries, contact OTC Markets Group Inc. at +1 (212) 896-4428 or [email protected]. Subscribe to the OTC Markets RSS Feed for updates.
In addition to Spryng™ with OsteoCushion™ technology, PetVivo's lead product PrecisePRP is also currently available for commercial sale. The company's focus remains on the licensing and commercialization of innovative medical devices and therapeutics for equine and companion animals.
This upgrade to the OTCQX Best Market marks an important step for PetVivo Holdings Inc., as it transitions from development to commercialization of veterinary biomedical devices, securing distribution partnerships and expanding manufacturing, all aimed at broadening its reach in the U.S. market.
- PetVivo Holdings Inc., a company based in Toronto, Canada, specializes in the manufacturing and commercialization of innovative health solutions for animals.
- The company's focus is on the development, licensing, and commercialization of medical devices and therapeutics for horses and companion animals, including products like Spryng® with OsteoCushion® Technology and PrecisePRP.
- To keep up with their expansion, PetVivo operates an ISO 7 certified clean room manufacturing facility in Minneapolis and plans to open a second facility to increase manufacturing capacity.
- As a company that prioritizes transparency and compliance, PetVivo has qualified to trade on the OTCQX Best Market, a designation reserved for established companies that meet high financial standards, follow best practice corporate governance, and adhere to securities laws.
- The media can reach out to OTC Markets Group Inc. for inquiries, and U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for PetVivo Holdings Inc. on the OTC Markets website.
